← Browse by Condition
Medical Condition
beta thalassemia
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3, Phase 2, Phase 1
NCT04064060 Phase 3
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Enrollment
665 pts
Location
United States, Austr...
Sponsor
Celgene
NCT04143724 Phase 2
Recruiting
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Enrollment
99 pts
Location
United States, China...
Sponsor
Celgene
NCT06772766 Phase 1
Recruiting
A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia
Enrollment
40 pts
Location
China
Sponsor
Mabwell (Shanghai) Bioscience ...